Is it safe to stop placing a drain after distal pancreatectomy? ➡️Today #PANDORINA non-inferiority trial 🇳🇱🇮🇹 The Lancet Gastroenterology & Hepatology ✅ Yes! Not only safe, but improves overall morbidity and POPF B/C rate! Wonderful collaboration DPCG & Pancreas Verona ➡️

Standing room only in the #SSO2024 Resident Program!! Society of Surgical Oncology Callisia Clarke MD

Great debates in #HPB Society of Surgical Oncology Alice Wei takes on David Kooby, MD - should we be chasing intraoperative margins in #PDAC #SSO2024 Julie Hallet

Standing room only for #SSO2024 great debates #PSM #HIPEC - prophylactic CRS/HIPEC in high risk T4 colorectal cancer? #Lambert vs Kostas Votanopoulos with Fabian Johnston, M.D., M.H.S keeping the peace 🥊Society of Surgical Oncology

Stellar 2nd year Department of Surgery at Cedars-Sinai Cedars-Sinai #CGSO fellow Eric Pletcher presenting our work on Single Cell Mass Cytometry 🔬in metastatic #neuroendocrine tumors. More data in this space will inform treatment and guide management #SSO2024 Society of Surgical Oncology NANETS LACNETS Andrew Bellizzi 🇺🇦

#SSO2024 oh what a night! Raising money 💰 and the roof for cancer ♋️ research 🔬! Society of Surgical Oncology UChicago Surgery UChicago Surgery Residents Endeavor Health

An amazing session today on all the hottest controversies for managing patients with Colorectal Peritoneal Metastases. So many questions we still need to answer! #SSO224 Jeremiah Deneve Maria Russell Anai N. Kothari Prakash Pandalai MD FACS Alexandra Gangi, MD Moffitt Cancer Center

Alexandra Gangi, MD Prakash Pandalai MD FACS Anai N. Kothari Maria Russell UNC Surgery Moffitt Cancer Center MCW Surgery Emory Surgery @CedasSinai

#letstalkaboutNETs Cancer at Cedars-Sinai stellar 2nd year #CGSO fellow! #SSO2024 Teodora Dumitra MD PhD FRCSC Ashley Russo Cedars-Sinai Gen Surg Residents Armando Giuliano Farin Amersi MarkFariesMD LACNETS Society of Surgical Oncology

Measuring quality in surgery for pancreatic NETs🦓 is crucial ‼️ ✔️Only 32% achieve textbook outcomes after surgery. ✔️Tumor size, approach, and volume are critical factors. ✔️Despite rising TO rates, survival remains unchanged ⁦AnnalsSurgOncology⁩ link.springer.com/article/10.124…

Lots of great discussion regarding the future of HCC AHPBA #AHPBA2024 Anjana Pillai Adam Yopp Mark Yarchoan Amit G Singal UT Southwestern Medical Center IHPBA

All star panel discussing multidisciplinary management of colorectal liver metastases (resection, transplant, systemic tx, hai, ablation… ) #CRLM AHPBA #AHPBA2024 Shimul A. Shah Hop S. Tran Cao Sepideh Gholami, MD, MAS, FACS, FSSO Kevin Billingsley MD, MBA COLONTOWN

Mesentery-sparing resection for SB-NETs - how much bowel can be saved? Anatomical study🔪: 1st jejunal branches perfuse good territory 📏1 & 2👉🏻mean 195 cm 📏1, 2 & 3👉🏻mean 335cm ➡️Many proximal mesenteric masses can be resected - spare 1st branches & ileo-cecal valve 📝👇🏻

Can we boost #HIPEC effectiveness with Bromelain? Exciting new research from #WFORCE group, reveals its dual action as a mucolytic and cytotoxic agent, against appendiceal cancer organoids.#cancerresearch #innovation Dive in the study here: rdcu.be/dGZE2

Dr. Adam #RCT TransMet initially unresectable #CRLM w/response to 3 mos chemo (<3 prior lines, no extrahep mets, CEA<80, no BRAF) 1:1 liver transplant (LT) + chemo vs chemo only ➡️ improved 5-yr OS w/LT, interesting patterns of relapse salvageable w/local tx #ASCO24 OncoAlert

Congratulations Micah J. Brainerd, M.D. !!!! We are so excited to have you join us! ☀️Farin Amersi Armando Giuliano Teodora Dumitra MD PhD FRCSC Cedars-Sinai Gen Surg Residents Timothy DiPeri, MD Cancer at Cedars-Sinai

Excited for the 4th annual Complex HPB Course Moffitt Cancer Center CAMLS and thrilled to have Jean-Nicolas Vauthey MD and Melissa Hogg joining this year as guest faculty! Society of Surgical Oncology Syed A. Ahmad Alexandra Gangi, MD Flavio G Rocha, MD, FACS, FSSO Timothy M. Pawlik Jennifer Tseng (IG: @tsengjennifermd)

1⃣of3⃣PNETs potentially over-treated especially small PNETs in expert centre (?higher elsewhere) 🔸Same OS over vs appropriate treatment 🔸25% overtreated pts have unnecessary morbidity! We can harm patients😳 🔸🏥NET MCC ⬇️overtreatment One of my fave📝 this year Stefano Partelli

🚨Awaited prospective data for neoadjuvant in PNETs BJS Single arm preop PRRT for high-risk PNET 👥31 patients ✔️59% response rate ✔️path response exists 36% fibrosis ✔️M&M profile not altered Important step forward - congrats Stefano Partelli! 📝👇🏻